Notice of Meeting, 29773 [2010-12544]

Download as PDF Federal Register / Vol. 75, No. 102 / Thursday, May 27, 2010 / Notices Research Special Emphasis Panel (SEP) meeting. A Special Emphasis Panel is a group of experts in fields related to health care research who are invited by the Agency for Healthcare Research and Quality (AHRQ), and agree to be available, to conduct on an as needed basis, scientific reviews of applications for AHRQ support. Individual members of the Panel do not attend regularlyscheduled meetings and do not serve for fixed terms or a long period of time. Rather, they are asked to participate in particular review meetings which require their type of expertise. Substantial segments of the upcoming SEP meeting listed below will be closed to the public in accordance with the Federal Advisory Committee Act, section 10 (d) of 5 U.S.C., Appendix 2 and 5 U.S.C. 552b (c)(6). Grant applications for the Recovery Act 2009 Limited Competition: Prospect Studies—Building New Clinical Infrastructure for CE (R01) applications are to be reviewed and discussed at this meeting. These discussions are likely to reveal personal information concerning individuals associated with the applications. This information is exempt from mandatory disclosure under the above-cited statutes. SEP Meeting on: Recovery Act 2009 Limited Competition: Prospect Studies— Building New Clinical Infrastructure for CE (R01). Dates: June 16, 2010. (Open on June 16 from 8 a.m. to 8:15 a.m. and closed for the remainder of the meeting.) Place: Hyatt Regency Hotel, 7400 Wisconsin Avenue, 1 Bethesda Metro Center, Conference Room TBD, Bethesda, MD 20814. Contact Person: Anyone wishing to obtain a roster of members, agenda or minutes of the nonconfidential portions of this meeting should contact Mrs. Bonnie Campbell, Committee Management Officer, Office of Extramural Research, Education and Priority Populations, AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850, Telephone (301) 427–1554. Agenda items for this meeting are subject to change as priorities dictate. Dated: May 13, 2010. Carolyn M. Clancy, Director. [FR Doc. 2010–12546 Filed 5–26–10; 8:45 am] wwoods2 on DSK1DXX6B1PROD with NOTICES BILLING CODE 4160–90–M U.S.C., Appendix 2), announcement is made of a Health Care Policy and Research Special Emphasis Panel (SEP) meeting. A Special Emphasis Panel is a group of experts in fields related to health care research who are invited by the Agency for Healthcare Research and Quality (AHRQ), and agree to be available, to conduct on an as needed basis, scientific reviews of applications for AHRQ support. Individual members of the Panel do not attend regularlyscheduled meetings and do not serve for fixed terms or a long period of time. Rather, they are asked to participate in particular review meetings which require their type of expertise. Substantial segments of the upcoming SEP meeting listed below will be closed to the public in accordance with the Federal Advisory Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C. 552b(c)(6). Grant applications for the OS ARRA: Enhancing Registries for Quality Improvement and Comparative Effectiveness (RO 1) applications are to be reviewed and discussed at this meeting. These discussions are likely to reveal personal information concerning individuals associated with the applications. This information is exempt from mandatory disclosure under the above-cited statutes. SEP Meeting on: OS ARRA: Enhancing Registries for Quality Improvement and Comparative Effectiveness (R01). Dates: June 18, 2010. (Open on June 18 from 8 a.m. to 8:15 a.m. and closed for the remainder of the meeting.) Place: Crowne Plaza Hotel, 3 Research Court, Conference Room TBD, Rockville, MD 20852. Contact Person: Anyone wishing to obtain a roster of members, agenda or minutes of the non-confidential portions of this meeting should contact Mrs. Bonnie Campbell, Committee Management Officer, Office of Extramural Research, Education and Priority Populations, AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850, Telephone (301) 427–1554. Agenda items for this meeting are subject to change as priorities dictate. Dated: May 13, 2010. Carolyn M. Clancy, Director. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2010–12544 Filed 5–26–10; 8:45 am] Agency for Healthcare Research and Quality BILLING CODE 4160–90–M Notice of Meeting In accordance with section 10(d) of the Federal Advisory Committee Act (5 VerDate Mar<15>2010 15:26 May 26, 2010 Jkt 220001 PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 29773 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, Collaborative Interdisciplinary Team Science—Nuclear Receptors. Date: June 10, 2010. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892. (Telephone Conference Call.) Contact Person: Robert Wellner, PhD, Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 757, 6707 Democracy Boulevard, Bethesda, MD 20892–5452. (301) 594–4721. rw175w@nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, Metabolic Disease and Pregnancy. Date: June 10, 2010. Time: 3:30 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892. (Telephone Conference Call.) Contact Person: Carol J. Goter-Robinson, PhD, Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 748, 6707 Democracy Boulevard, Bethesda, MD 20892–5452. (301) 594–7791. goterrobinsonc@extra.niddk.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases E:\FR\FM\27MYN1.SGM 27MYN1

Agencies

[Federal Register Volume 75, Number 102 (Thursday, May 27, 2010)]
[Notices]
[Page 29773]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-12544]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Notice of Meeting

    In accordance with section 10(d) of the Federal Advisory Committee 
Act (5 U.S.C., Appendix 2), announcement is made of a Health Care 
Policy and Research Special Emphasis Panel (SEP) meeting.
    A Special Emphasis Panel is a group of experts in fields related to 
health care research who are invited by the Agency for Healthcare 
Research and Quality (AHRQ), and agree to be available, to conduct on 
an as needed basis, scientific reviews of applications for AHRQ 
support. Individual members of the Panel do not attend regularly-
scheduled meetings and do not serve for fixed terms or a long period of 
time. Rather, they are asked to participate in particular review 
meetings which require their type of expertise.
    Substantial segments of the upcoming SEP meeting listed below will 
be closed to the public in accordance with the Federal Advisory 
Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C. 
552b(c)(6). Grant applications for the OS ARRA: Enhancing Registries 
for Quality Improvement and Comparative Effectiveness (RO 1) 
applications are to be reviewed and discussed at this meeting. These 
discussions are likely to reveal personal information concerning 
individuals associated with the applications. This information is 
exempt from mandatory disclosure under the above-cited statutes.

    SEP Meeting on: OS ARRA: Enhancing Registries for Quality 
Improvement and Comparative Effectiveness (R01).
    Dates: June 18, 2010. (Open on June 18 from 8 a.m. to 8:15 a.m. 
and closed for the remainder of the meeting.)
    Place: Crowne Plaza Hotel, 3 Research Court, Conference Room 
TBD, Rockville, MD 20852.
    Contact Person: Anyone wishing to obtain a roster of members, 
agenda or minutes of the non-confidential portions of this meeting 
should contact Mrs. Bonnie Campbell, Committee Management Officer, 
Office of Extramural Research, Education and Priority Populations, 
AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850, 
Telephone (301) 427-1554.
    Agenda items for this meeting are subject to change as 
priorities dictate.

    Dated: May 13, 2010.
Carolyn M. Clancy,
Director.
[FR Doc. 2010-12544 Filed 5-26-10; 8:45 am]
BILLING CODE 4160-90-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.